Phenotypic Screening in Early Drug Discovery: Opportunities and Challenges

Despite the prevalence of target-based discovery, phenotypic screening is emerging as a popular technique in early drug discovery. Challenges with target-based delivery have shown obvious flaws with predictive validity. The latest application of AI in phenotypic drug discovery has shown...

6 years ago
Precision and Personalised Medicine,Biology,News

Phenotypic Screening in Early Drug Discovery: Opportunities and Challenges

Despite the prevalence of target-based discovery, phenotypic screening is emerging as a popular technique in early drug discovery. Challenges with target-based delivery have shown obvious flaws with predictive validity. The latest application of AI in phenotypic drug discovery has shown...

6 years ago

Precision Medicine in Oncology: A Comparative Evaluation of SMDCs and ADCs

Targeted therapy - a treatment targeting proteins responsible for cancer growth - is one of the latest developments in precision oncology. The variable response of cancer treatments highlights the need to develop therapies that can target the specific profile of...

6 years ago
Oncology,Clinical Operations,Biology,News

Precision Medicine in Oncology: A Comparative Evaluation of SMDCs and ADCs

Targeted therapy - a treatment targeting proteins responsible for cancer growth - is one of the latest developments in precision oncology. The variable response of cancer treatments highlights the need to develop therapies that can target the specific profile of...

6 years ago

Disease Models and Target Validation: An Interview with Professor Gavin Woodhall

In a recent interview with Proventa, Professor Gavin Woodhall, research scientist and Head of Neuroscience at Aston University, discussed the challenges of modelling human disease and the impact of alternative models on target validation. Professor Woodhall has an extensive academic...

6 years ago
R&D,Biology,News

Disease Models and Target Validation: An Interview with Professor Gavin Woodhall

In a recent interview with Proventa, Professor Gavin Woodhall, research scientist and Head of Neuroscience at Aston University, discussed the challenges of modelling human disease and the impact of alternative models on target validation. Professor Woodhall has an extensive academic...

6 years ago

An Evaluation of Data Capture and Visualization in Clinical Research

Data capture and visualization are the key components of clinical trial data analysis. However, with the explosion of COVID-19 around the world, data collection became difficult with poor patient recruitment and a reduction in face-to-face clinics. Advancements in telehealth have...

6 years ago
Bioinformatics,Biology,News

An Evaluation of Data Capture and Visualization in Clinical Research

Data capture and visualization are the key components of clinical trial data analysis. However, with the explosion of COVID-19 around the world, data collection became difficult with poor patient recruitment and a reduction in face-to-face clinics. Advancements in telehealth have...

6 years ago

Challenges of Modelling Human Disease – Optimising Target Validation

The complexity of the human body presents a challenge when choosing a model that is translatable and can also be manipulated for target validation. In addition to the popular animal models, recent innovations in computational biology has seen significant advancements...

6 years ago
R&D,Biology

Challenges of Modelling Human Disease – Optimising Target Validation

The complexity of the human body presents a challenge when choosing a model that is translatable and can also be manipulated for target validation. In addition to the popular animal models, recent innovations in computational biology has seen significant advancements...

6 years ago

The Clinical Challenges of Rare Disease Research: An Interview with Dr. Evangeline Wassmer

In a recent interview with Dr. Evangeline Wassmer, Paediatric neurology consultant at Birmingham Children’s Hospital, Proventa discussed the problems with rare disease clinical research. Dr. Wassmer has extensive experience in paedatric rare diseases -  paediatric Multiple Sclerosis, neurometabolic and neurodegenerative...

6 years ago
Clinical Development,Clinical Operations,Precision and Personalised Medicine,Biology,News

The Clinical Challenges of Rare Disease Research: An Interview with Dr. Evangeline Wassmer

In a recent interview with Dr. Evangeline Wassmer, Paediatric neurology consultant at Birmingham Children’s Hospital, Proventa discussed the problems with rare disease clinical research. Dr. Wassmer has extensive experience in paedatric rare diseases -  paediatric Multiple Sclerosis, neurometabolic and neurodegenerative...

6 years ago
Previous Page Showing 222 out of 323 Next Page
Working With us

Interested?
Reserve your space